# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-21-237049
Filing Date
2021-08-05
Accepted
2021-08-05 08:07:16
Documents
48
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d209239d8k.htm iXBRL | 8-K | 27118
2 | EX-99.1 | d209239dex991.htm | EX-99.1 | 76215
3 | EX-99.2 | d209239dex992.htm | EX-99.2 | 33768
7 | GRAPHIC | g209239ex99_2s10g1.jpg | GRAPHIC | 431629
8 | GRAPHIC | g209239ex99_2s11g1.jpg | GRAPHIC | 548877
9 | GRAPHIC | g209239ex99_2s12g1.jpg | GRAPHIC | 630348
10 | GRAPHIC | g209239ex99_2s13g1.jpg | GRAPHIC | 517184
11 | GRAPHIC | g209239ex99_2s14g1.jpg | GRAPHIC | 266318
12 | GRAPHIC | g209239ex99_2s15g1.jpg | GRAPHIC | 649769
13 | GRAPHIC | g209239ex99_2s16g1.jpg | GRAPHIC | 445900
14 | GRAPHIC | g209239ex99_2s17g1.jpg | GRAPHIC | 509603
15 | GRAPHIC | g209239ex99_2s18g1.jpg | GRAPHIC | 515181
16 | GRAPHIC | g209239ex99_2s19g1.jpg | GRAPHIC | 651276
17 | GRAPHIC | g209239ex99_2s1g1.jpg | GRAPHIC | 271801
18 | GRAPHIC | g209239ex99_2s20g1.jpg | GRAPHIC | 694743
19 | GRAPHIC | g209239ex99_2s21g1.jpg | GRAPHIC | 429345
20 | GRAPHIC | g209239ex99_2s22g1.jpg | GRAPHIC | 659708
21 | GRAPHIC | g209239ex99_2s23g1.jpg | GRAPHIC | 520259
22 | GRAPHIC | g209239ex99_2s24g1.jpg | GRAPHIC | 704308
23 | GRAPHIC | g209239ex99_2s25g1.jpg | GRAPHIC | 594638
24 | GRAPHIC | g209239ex99_2s26g1.jpg | GRAPHIC | 634927
25 | GRAPHIC | g209239ex99_2s27g1.jpg | GRAPHIC | 645862
26 | GRAPHIC | g209239ex99_2s28g1.jpg | GRAPHIC | 581916
27 | GRAPHIC | g209239ex99_2s29g1.jpg | GRAPHIC | 656514
28 | GRAPHIC | g209239ex99_2s2g1.jpg | GRAPHIC | 1001297
29 | GRAPHIC | g209239ex99_2s30g1.jpg | GRAPHIC | 584874
30 | GRAPHIC | g209239ex99_2s31g1.jpg | GRAPHIC | 442896
31 | GRAPHIC | g209239ex99_2s32g1.jpg | GRAPHIC | 222005
32 | GRAPHIC | g209239ex99_2s3g1.jpg | GRAPHIC | 513954
33 | GRAPHIC | g209239ex99_2s4g1.jpg | GRAPHIC | 746308
34 | GRAPHIC | g209239ex99_2s5g1.jpg | GRAPHIC | 688574
35 | GRAPHIC | g209239ex99_2s6g1.jpg | GRAPHIC | 412518
36 | GRAPHIC | g209239ex99_2s7g1.jpg | GRAPHIC | 497606
37 | GRAPHIC | g209239ex99_2s8g1.jpg | GRAPHIC | 782449
38 | GRAPHIC | g209239ex99_2s9g1.jpg | GRAPHIC | 530766
39 | GRAPHIC | g209239g37o44.jpg | GRAPHIC | 3996
40 | GRAPHIC | g209239g84v48.jpg | GRAPHIC | 3781
| Complete submission text file | 0001193125-21-237049.txt |  | 25062167

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | cbio-20210805.xsd | EX-101.SCH | 2923
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cbio-20210805_lab.xml | EX-101.LAB | 18137
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cbio-20210805_pre.xml | EX-101.PRE | 11428
41 | EXTRACTED XBRL INSTANCE DOCUMENT | d209239d8k_htm.xml | XML | 3341

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211146424
SIC: 2834 Pharmaceutical Preparations